Ardent phase 2b clinical trial of IMR-687 : Imara wraps up patient enrollment

Imara Inc. said that it has wrapped up enrollment of patients in the Ardent phase 2b clinical trial of IMR-687 (tovinontrine) for sickle cell disease. ... Read More